Outcome of First‐Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell Chondrosarcoma

BACKGROUND. Chondrosarcoma is a heterogeneous group of primary bone sarcoma with an excellent overall survival after local therapy. However, the small percentage of patients who have no surgical treatment options have a very poor prognosis. We retrospectively collected data from these patients in fo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: van Maldegem, Annemiek, Conley, Anthony P., Rutkowski, Piotr, Patel, Shreyaskumar R., Lugowska, Iwona, Desar, Ingrid M.E., Bovée, Judith V.M.G., Gelderblom, Hans
Natura: Artigo
Lingua:Inglês
Pubblicazione: AlphaMed Press 2018
Soggetti:
Sarcomas
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324625/
https://ncbi.nlm.nih.gov/pubmed/30082492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0574
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi